Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 1
1994 1
1997 1
1998 1
2000 2
2002 2
2005 1
2006 1
2008 1
2009 1
2010 2
2011 2
2012 3
2014 4
2016 2
2017 4
2018 8
2019 6
2020 2
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
Beck LA, Thaçi D, Deleuran M, Blauvelt A, Bissonnette R, de Bruin-Weller M, Hide M, Sher L, Hussain I, Chen Z, Khokhar FA, Beazley B, Ruddy M, Patel N, Graham NMH, Ardeleanu M, Shumel B. Beck LA, et al. Am J Clin Dermatol. 2020 Aug;21(4):567-577. doi: 10.1007/s40257-020-00527-x. Am J Clin Dermatol. 2020. PMID: 32557382 Free PMC article. Clinical Trial.
OBJECTIVE: The aim of this study was to report the safety and efficacy of dupilumab treatment for up to 3 years in adults with moderate-to-severe AD. METHODS: This ongoing, multicenter, open-label extension study (LIBERTY AD OLE; NCT01949311) assessed dupilumab treatment i …
OBJECTIVE: The aim of this study was to report the safety and efficacy of dupilumab treatment for up to 3 years in adults with modera …
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study.
Dieci MV, Guarneri V, Zustovich F, Mion M, Morandi P, Bria E, Merlini L, Bullian P, Oliani C, Gori S, Giarratano T, Orvieto E, Griguolo G, Michieletto S, Saibene T, Del Bianco P, De Salvo GL, Conte P; Veneto Oncology Network. Dieci MV, et al. Oncologist. 2019 Nov;24(11):1424-1431. doi: 10.1634/theoncologist.2019-0103. Epub 2019 May 31. Oncologist. 2019. PMID: 31152079 Free PMC article.
BACKGROUND: The ROXANE Italian prospective study evaluated the impact of the 21-gene Recurrence Score (RS) results on adjuvant treatment decision for patients with early breast cancer. ...
BACKGROUND: The ROXANE Italian prospective study evaluated the impact of the 21-gene Recurrence Score (RS) results on adjuvant treatm …
Placebo-blinded study of morphine sulfate sustained-release tablets and immediate-release morphine sulfate solution in outpatients with chronic pain due to advanced cancer.
Finn JW, Walsh TD, MacDonald N, Bruera E, Krebs LU, Shepard KV. Finn JW, et al. J Clin Oncol. 1993 May;11(5):967-72. doi: 10.1200/JCO.1993.11.5.967. J Clin Oncol. 1993. PMID: 8487059 Clinical Trial.
PATIENTS AND METHODS: This was a double-blind, placebo-blinded, crossover study in 34 adult male and female outpatients with pain due to advanced cancer. ...On days 2 and 3, randomly assigned patients received either placebo plus IRM (Roxanol; Roxane Laboratories, I …
PATIENTS AND METHODS: This was a double-blind, placebo-blinded, crossover study in 34 adult male and female outpatients with pain due …
Combined gastric and ileocecal toxicity (serpiginous ulcers) after oral kayexalate in sorbital therapy.
Roy-Chaudhury P, Meisels IS, Freedman S, Steinman TI, Steer M. Roy-Chaudhury P, et al. Am J Kidney Dis. 1997 Jul;30(1):120-2. doi: 10.1016/s0272-6386(97)90574-6. Am J Kidney Dis. 1997. PMID: 9214411
Kayexalate (Roxane Labs, Columbus, OH) in sorbitol is commonly administered by the oral and rectal route for the treatment of hyperkalemia in patients with renal failure. ...
Kayexalate (Roxane Labs, Columbus, OH) in sorbitol is commonly administered by the oral and rectal route for the treatment of hyperka …
Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
Lane M, Vogel CL, Ferguson J, Krasnow S, Saiers JL, Hamm J, Salva K, Wiernik PH, Holroyde CP, Hammill S, et al. Lane M, et al. J Pain Symptom Manage. 1991 Aug;6(6):352-9. doi: 10.1016/0885-3924(91)90026-z. J Pain Symptom Manage. 1991. PMID: 1652611 Free article. Clinical Trial.
Dronabinol (Marinol, Roxane Laboratories, Columbus, OH) and prochlorperazine were tested alone and in combination in a randomized, double-blind, parallel group, multicenter study. ...
Dronabinol (Marinol, Roxane Laboratories, Columbus, OH) and prochlorperazine were tested alone and in combination in a randomized, do …
Intraoperative use of Toradol facilitates outpatient hemorrhoidectomy.
O'Donovan S, Ferrara A, Larach S, Williamson P. O'Donovan S, et al. Dis Colon Rectum. 1994 Aug;37(8):793-9. doi: 10.1007/BF02050144. Dis Colon Rectum. 1994. PMID: 8055724 Clinical Trial.
Results were compared with two other groups of matching patients: one group (narcotics, n = 18) treated with standard postoperative narcotic intramuscular/oral analgesics after overnight hospital stay, and a group (SQMP, n = 21) previously treated by one of us with outpatient, su …
Results were compared with two other groups of matching patients: one group (narcotics, n = 18) treated with standard postoperative narcotic …
An evaluation of the effect of food on the oral bioavailability of sustained-release morphine sulfate tablets (ORAMORPH SR) after multiple doses.
Bass J, Shepard KV, Lee JW, Hulse J. Bass J, et al. J Clin Pharmacol. 1992 Nov;32(11):1003-7. doi: 10.1002/j.1552-4604.1992.tb03802.x. J Clin Pharmacol. 1992. PMID: 1474160 Clinical Trial.
The effect of food on the oral bioavailability of sustained-release morphine sulfate tablets (ORAMORPH SR; Roxane Laboratories, Inc., Columbus, OH; OSR) was examined in an open-label, randomized, two-period crossover study. ...
The effect of food on the oral bioavailability of sustained-release morphine sulfate tablets (ORAMORPH SR; Roxane Laboratories, Inc., …
Grief in Veterans: An Unexplored Consequence of War.
Lubens P, Silver RC. Lubens P, et al. Am J Public Health. 2019 Mar;109(3):394-395. doi: 10.2105/AJPH.2018.304924. Am J Public Health. 2019. PMID: 30726138 Free PMC article. No abstract available.
Gastrointestinal thermal homogeneity and effect of cold water ingestion.
Roxane B, Ouma Chandrou K, Pierre Alexandre C, Christophe C, Bruno S, Stéphane B, Hervé N, Sébastien M, Nicolas B. Roxane B, et al. J Therm Biol. 2018 Dec;78:204-208. doi: 10.1016/j.jtherbio.2018.10.002. Epub 2018 Oct 13. J Therm Biol. 2018. PMID: 30509636
49 results